Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01709630 · ClinicalTrials.gov registry record
PK/PD Modeling of Magnesium in the Mother and Neonate
A clinical trial of Magnesium Sulfate Pharmacokinetics and Pharmacodynamics, sponsored by Stanford University.
- Completed
- Registry status
- 151
- Enrollment target
- 1
- Study location
NCT01709630: Completed study of Magnesium Sulfate Pharmacokinetics and Pharmacodynamics, sponsored by Stanford University.
NCT01709630 is a study of Magnesium Sulfate Pharmacokinetics and Pharmacodynamics that has completed, run by Stanford University. The registered enrollment target is 151 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01709630, a study of Magnesium Sulfate Pharmacokinetics and Pharmacodynamics, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 151 participants
- Enrollment target
- 1
- Study location
Study Summary
Determine significant correlations between maternal serum magnesium levels, and maternal and neonatal outcomes.
Primary Outcome
Pregnant women and neonates exposed to magnesium sulfate for preeclampsia, tocolysis, or neuroprotection will have blood samples drawn at set time points around the time of delivery.
Conditions Studied
Interventions
- DRUG Magnesium sulfate infusion
Study Locations (1)
California
- Lucille Packard Children's Hospital at Stanford University Medical Center - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2012-09 |
| Est. Completion | 2014-10 |
What the finished NCT01709630 record still lists
NCT01709630 is an observational study that tracks outcomes without assigning an intervention. The registered 151 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Magnesium Sulfate Pharmacokinetics and Pharmacodynamics appearing as the primary indexed condition, and to 1 intervention - of which Magnesium sulfate infusion is the first listed.
NCT01709630 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01709630 about?
NCT01709630 is a clinical study titled "PK/PD Modeling of Magnesium in the Mother and Neonate". Determine significant correlations between maternal serum magnesium levels, and maternal and neonatal outcomes.
What is the current status of trial NCT01709630?
This trial is currently completed. The enrollment target is 151 participants. The study started on 2012-09. Estimated completion is 2014-10.
What conditions does trial NCT01709630 study?
This clinical trial studies the following conditions: Magnesium Sulfate Pharmacokinetics and Pharmacodynamics.
What interventions are being tested in trial NCT01709630?
The interventions under investigation include: Magnesium sulfate infusion (DRUG).
Who is sponsoring clinical trial NCT01709630?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01709630 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01409161 · 151 participants · Phase 2
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
- NCT04245397 · 151 participants · Phase 1
Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
- NCT05761223 · 151 participants · Phase 1
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
- NCT07195656 · 151 participants · NA
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia